Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide
Abstract
Circumstantial evidence has suggested that activated microglia may be associated with the pathogenesis of depression. Pro-inflammatory cytokines may also be involved. Therefore, we examined the effects of various types of antidepressants, as well as the mood-stabilizer lithium chloride, on interferon-gamma (IFN-gamma)-induced microglial production of the pro-inflammatory mediators interleukin-6 (IL-6) and nitric oxide (NO). Treatment of the murine microglial 6-3 cells with 100 U/ml of IFN-gamma resulted in an eightfold increase in IL-6 and a tenfold increase in NO into the culture medium. Pretreatment with the selective serotonin reuptake inhibitor fluvoxamine, the relatively selective noradrenaline reuptake inhibitor reboxetine, or the non-selective monoaminergic reuptake inhibitor imipramine, significantly inhibited IL-6 and NO production in a dose-dependent manner. These inhibitions were reversed significantly by SQ 22536, a cyclic adenosine monophosphate (cAMP) inhibitor, and, except for reboxetine, by the protein kinase A (PKA) inhibitor Rp-adenosine3',5'-cyclic monophosphorothioate triethylammonium salt (Rp-3',5'-cAMPS). Lithium chloride, which is believed to act by inhibiting the calcium-dependent release of noradrenaline, had a different spectrum of action on microglial 6-3 cells. It enhanced IFN-gamma-stimulated IL-6 production and inhibited NO production. The inhibitory effect of lithium chloride was not reversed by either SQ 22536 or Rp-3',5'-cAMPS. These results suggest that antidepressants have inhibitory effects on IFN-gamma-activated microglia and these effects are, at least partially, mediated by the cAMP-dependent PKA pathway. On the other hand, the mood stabilizer and anti-manic agent lithium chloride has mixed effects on IFN-gamma-induced microglial activation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pretreatment with imipramine, fluvoxamine, or reboxetine inhibits NO production in a dose-dependent manner in an activated microglia cell culture protocol.
“pretreatment with imipramine, fluvoxamine, or reboxetine inhibited NO production in a dose-dependent manner in an activated microglia cell culture protocol [11].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [11]
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · see citing works
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · see citing works
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426 · see citing works
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559 · see citing works
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235 · see citing works
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940 · see citing works
Self-citationThe macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · see citing works
Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.-G., & Bogerts, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.013 · Cited by 791 · see citing works
Depression: a case of neuronal life and death?
Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 612 · see citing works
Vallières, L., Campbell, I. L., Gage, F. H., & Sawchenko, P. E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00486.2002 · Cited by 598 · see citing works
Inflammation and the Degenerative Diseases of Aging
McGeer, P. L., & McGeer, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 519 · see citing works
Self-citationMaes, M. H. J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357 · see citing works
Kubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343 · see citing works
Xia, Z., DePierre, J. W., & Nässberger, L. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00111-7 · Cited by 318 · see citing works
Signal transduction of inflammatory cytokines and tumor development
Yoshimura, A. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00197.x · Cited by 314 · see citing works
Maes, M., Scharpé, S., Meltzer, H. Y., Okayli, G., Bosmans, E., D'Hondt, P., Vanden Bossche, B., & Cosyns, P. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90003-5 · Cited by 302 · see citing works
Novel therapeutic approaches beyond the serotonin receptor
Duman, R. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00031-6 · Cited by 239 · see citing works
Moreno‐López, B., Romero‐Grimaldi, C., Noval, J. A., Murillo‐Carretero, M., Matarredona, E. R., & Estrada, C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1574-03.2004 · Cited by 230 · see citing works
Zhu, D. Y., Liu, S. H., Sun, H., & Lu, Y. M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00223.2003 · Cited by 216 · see citing works
Brustolim, D., Ribeiro‐dos‐Santos, R., Kast, R. E., Altschuler, E. L., & Soares, M. B. P. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2005.12.007 · Cited by 195 · see citing works
Antidepressant action: to the nucleus and beyond
Malberg, J. E., & Blendy, J. A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.005 · Cited by 193 · see citing works
De La Garza, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.016 · Cited by 153 · see citing works
Wong, M., Whelan, F., Deloukas, P., Whittaker, P., Delgado, M., Cantor, R. M., McCann, S. M., & Licinio, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602795103 · Cited by 145 · see citing works
Effects of antidepressants on cytokine production and actions
Castanon, N., Leonard, B. E., Neveu, P. J., & Yirmiya, R. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00008-9 · Cited by 143 · see citing works
Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?
Mowla, A., Mosavinasab, M., & Pani, A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e0002 · Cited by 141 · see citing works
Stimulatory effect of antidepressants on the production of IL-6
Kubera, M., Kenis, G., Bosmans, E., Kajta, M., Basta-Kaim, A., Scharpe, S., Budziszewska, B., & Maes, M. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2003.11.006 · Cited by 126 · see citing works
Obuchowicz, E., Kowalski, J., Labuzek, K., Krysiak, R., Pendzich, J., & Herman, Z. S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500547x · Cited by 115 · see citing works
Reif, A., Schmitt, A. G., Fritzen, S., Chourbaji, S., Bartsch, C., Urani, A., Wycislo, M., Mößner, R., Sommer, C., Gass, P., et al. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03559.x · Cited by 100 · see citing works
Pharmacological characterization and visualization of the glial serotonin transporter
Inazu, M., Takeda, H., Ikoshi, H., Sugisawa, M., Uchida, Y., & Matsumiya, T. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00010-9 · Cited by 87 · see citing works
Dual role of nitric oxide in adult neurogenesis
Cárdenas, A., Moro, M. Á., Hurtado, O., Leza, J. C., & Lizasoaín, I. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.006 · Cited by 75 · see citing works
The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway
Maes, M. H. J., Kenis, G., Kubera, M., de Baets, M., Steinbusch, H. W. M., & Bosmans, E. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.11.008 · Cited by 64 · see citing works
Nitric Oxide Exposure Diverts Neural Stem Cell Fate from Neurogenesis Towards Astrogliogenesis
Covacu, R., Danilov, A. I., Rasmussen, B. S., Hallén, K., Moe, M. C., Lobell, A., Johansson, C. B., Svensson, M. A., Olsson, T. P., & Brundin, L. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0640 · Cited by 63 · see citing works
Depression, cytokines, and glial function
Miller, D. B., & O'Callaghan, J. P. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.011 · Cited by 62 · see citing works
Ha, E., Jung, K. H., Choe, B., Bae, J., Shin, D.-H., Yim, S., & Baik, H. H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.022 · Cited by 60 · see citing works
Reboxetine: Functional Inhibition of Monoamine Transporters and Nicotinic Acetylcholine Receptors
Miller, D. K., Wong, E. H. F., Chesnut, M. D., & Dwoskin, L. P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.2.687 · Cited by 60 · see citing works
In vitro immunoregulatory effects of antidepressants in healthy volunteers.
Szuster‐Ciesielska, A., Tustanowska-Stachura, A., Słotwińska, M., Marmurowska-Michałowska, H., & Kandefer‐Szerszeń, M. (2003) · PubMed · Cited by 60 · see citing works
Hormonal regulation of the NF-κB signaling pathway
Delfino, F. J., & Walker, W. H. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00127-6 · Cited by 53 · see citing works
Arena, A., Capozza, A., Orlando, M. E., Curro, F., Losi, E., Chillemi, S., Mesiti, M., & Merendino, R. A. (1997) · Journal of Chemotherapy · doi:10.1179/joc.1997.9.3.219 · Cited by 25 · see citing works
Effects of lithium carbonate on cytokine production in patients affected by breast cancer.
Merendino, R. A., Mancuso, G., Tomasello, F. F., Gazzara, D., Cusumano, V., Chillemi, S., Spadaro, P., & Mesiti, M. (1994) · PubMed · Cited by 24 · see citing works
Hashioka, S., Han, Y.-H., Fujii, S., Kato, T. A., Monji, A., Utsumi, H., Sawada, M., Nakanishi, H., & Kanba, S. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.10.006 · Cited by 24 · see citing works
Self-citationWeinberger, S. B., Schulteis, G., Fernando, A. G., Bakhit, C., & Martinez, J. L. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90564-4 · Cited by 22 · see citing works
Shinpo (2000) · doi:10.1002/1097-4547(20001101)62:3
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Interleukin-6, a Major Cytokine in the Central Nervous System
Erta, M., Quintana, A., & Hidalgo, J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4679 · Cited by 1,093 · see citing works
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944 · see citing works
Kreisel, T., Frank, M. G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M. V., Maier, S. F., & Yirmiya, R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.155 · Cited by 663 · see citing works
Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443 · see citing works
Inflammation and depression: a causal or coincidental link to the pathophysiology?
Leonard, B. E. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.69 · Cited by 409 · see citing works
Tynan, R. J., Weidenhofer, J., Hinwood, M., Cairns, M. J., Day, T. A., & Walker, F. R. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.12.011 · Cited by 382 · see citing works
Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)
Beurel, E., Michalek, S. M., & Jope, R. S. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.09.007 · Cited by 378 · see citing works
Neurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in bioscience · doi:10.2741/3598 · Cited by 369 · see citing works
Khairova, R. A., Machado-Vieira, R., Du, J., & Manji, H. K. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009924 · Cited by 350 · see citing works
Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity, Phenotype and Function
Walker, F. R., Nilsson, M., & Jones, K. (2013) · Current Drug Targets · doi:10.2174/13894501113149990208 · Cited by 324 · see citing works
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325 · see citing works
Depression's Unholy Trinity: Dysregulated Stress, Immunity, and the Microbiome
Cruz-Pereira, J. S., Rea, K., Nolan, Y. M., O'Leary, O. F., Dinan, T. G., & Cryan, J. F. (2020) · Annual Review of Psychology · doi:10.1146/annurev-psych-122216-011613 · Cited by 320 · see citing works
Microglial Dysregulation in Psychiatric Disease
Frick, L. R., Williams, K., & Pittenger, C. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/608654 · Cited by 299 · see citing works
Inflammation, Glutamate, and Glia in Depression:<i>A Literature Review</i>
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289 · see citing works
Loftis, J. M., Huckans, M. S., & Morasco, B. J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.015 · Cited by 252 · see citing works
Lee, M., Cho, T., Jantaratnotai, N., Wang, Y. T., McGeer, E. G., & McGeer, P. L. (2010) · The FASEB Journal · doi:10.1096/fj.09-149997 · Cited by 239 · see citing works
Self-citationA psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240 · see citing works
Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells
Liu, D., Wang, Z., Liu, S., Wang, F., Zhao, S., & Hao, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.033 · Cited by 221 · see citing works
Effects of Lithium on Inflammation
Nassar, A., & Azab, A. N. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500038f · Cited by 218 · see citing works
Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205 · see citing works
Suicide and Microglia: Recent Findings and Future Perspectives Based on Human Studies
Suzuki, H., Ohgidani, M., Kuwano, N., Chrétien, F., Lorin de la Grandmaison, G., Onaya, M., Tominaga, I., Setoyama, D., Kang, D., Mimura, M., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00031 · Cited by 198 · see citing works
Self-citationInhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants
Hwang, J., Zheng, L. T., Ock, J., Lee, M. G., Kim, S.-H., Lee, H.-W., Lee, W.-H., Park, H.-C., & Suk, K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.045 · Cited by 181 · see citing works
Feinstein, D. L., Kalinin, S., & Braun, D. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13447 · Cited by 178 · see citing works
Walker, F. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.002 · Cited by 175 · see citing works
Wager‐Smith, K., & Markou, A. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.010 · Cited by 150 · see citing works
The Relationship Between the Gut Microbiome-Immune System-Brain Axis and Major Depressive Disorder
Foster, J. A., Baker, G. B., & Dursun, S. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.721126 · Cited by 153 · see citing works
Leonard, B. E. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.018 · Cited by 129 · see citing works
Horikawa, H., Kato, T. A., Mizoguchi, Y., Monji, A., Seki, Y., Ohkuri, T., Gotoh, L., Yonaha, M., Ueda, T., Hashioka, S., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.015 · Cited by 116 · see citing works
Self-citationMartino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111 · see citing works
Ramírez, K., & Sheridan, J. F. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.008 · Cited by 111 · see citing works
Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance
Ramirez, K., Shea, D. T., McKim, D. B., Reader, B. F., & Sheridan, J. F. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.01.016 · Cited by 108 · see citing works
A neuroimmunological perspective on anxiety disorders
Hou, R. H., & Baldwin, D. S. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1259 · Cited by 107 · see citing works
Lee, M., Sparatore, A., Soldato, P. D., McGeer, E. G., & McGeer, P. L. (2009) · Glia · doi:10.1002/glia.20905 · Cited by 104 · see citing works
Self-citationPutative neuroprotective agents in neuropsychiatric disorders
Dodd, S., Maes, M. H. J., Anderson, G., Dean, O. M., Moylan, S., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.007 · Cited by 105 · see citing works
Effect of Antidepressants on the Course of Disability Following Stroke
Mikami, K., Jorge, R. E., Adams, H. P., Davis, P. H., Leira, E. C. C., Jang, M., & Robinson, R. G. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31821181b0 · Cited by 103 · see citing works
Watkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100 · see citing works
Yang, M., Qiu, W., Chen, J., Zhan, J., Pan, C., Lei, X., & Wu, M. (2014) · Aquatic Toxicology · doi:10.1016/j.aquatox.2013.12.029 · Cited by 100 · see citing works
Dunjic-Kostic, B., Ivkovic, M., Radonjic, N. V., Petronijevic, N. D., Pantovic, M., Damjanovic, A., Poznanovic, S. T., Jovanovic, A., Nikolic, T., & Jasovic-Gasic, M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.009 · Cited by 99 · see citing works
Ghasemi, M., Sadeghipour, H., Mosleh, A., Sadeghipour, H. R., Mani, A. R., & Dehpour, A. R. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.07.011 · Cited by 96 · see citing works
Review: the role of inflammation in depression.
Patel, A. J. (2013) · PubMed · Cited by 96 · see citing works
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95 · see citing works
Modulation of microglial activation by antidepressants
Mariani, N., Everson, J., Pariante, C. M., & Borsini, A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069110 · Cited by 92 · see citing works
Tryptophan: The key to boosting brain serotonin synthesis in depressive illness
Badawy, A. A. ‐. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113499209 · Cited by 91 · see citing works
Gao, F., Baozhong, D., Zhou, L., Gao, X., Guo, H., & Xu, H. Y. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.03.034 · Cited by 90 · see citing works
Black, C. N., Bot, M., Scheffer, P. G., & Penninx, B. W. J. H. (2016) · Psychological Medicine · doi:10.1017/s0033291716002828 · Cited by 88 · see citing works
Vollmar, P., Nessler, S., Kalluri, S. R., Hartung, H., & Hemmer, B. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009425 · Cited by 87 · see citing works
The role of macrophages in anti-inflammatory activity of antidepressant drugs
Nazimek, K., Strobel, S. D., Bryniarski, P., Kozlowski, M., Filipczak-Bryniarska, I., & Bryniarski, K. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.07.001 · Cited by 88 · see citing works
Quercetin, not caffeine, is a major neuroprotective component in coffee
Lee, M., McGeer, E. G., & McGeer, P. L. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.015 · Cited by 86 · see citing works
Self-citationAn Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants
Das, A., Ranadive, N., Kinra, M., Nampoothiri, M., Arora, D. S., & Mudgal, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200221113842 · Cited by 85 · see citing works
Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
Beurel, E. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00018 · Cited by 82 · see citing works
Implications of Systemic Inflammation and Periodontitis for Major Depression
Hashioka, S., Inoue, K., Hayashida, M., Wake, R., Oh‐Nishi, A., & Miyaoka, T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00483 · Cited by 84 · see citing works
Self-citationUpdate on the Relationship Between Depression and Neuroendocrine Metabolism
Qiu, W., Cai, X., Zheng, C., Qiu, S., Ke, H., & Huang, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.728810 · Cited by 86 · see citing works
Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
Gallego‐Landin, I., García-Baos, A., Castro‐Zavala, A., & Valverde, O. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.762738 · Cited by 84 · see citing works
Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro
Su, F., Yi, H., Xu, L., & Zhang, Z. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.028 · Cited by 81 · see citing works
Astrocytes and Microglia: Responses to Neuropathological Conditions
Singh, S., Swarnkar, S., Goswami, P., & Nath, C. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.598981 · Cited by 77 · see citing works
The NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithium
Ghasemi, M., & Dehpour, A. R. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.03.006 · Cited by 77 · see citing works
Visentin, A. P. V., Colombo, R., Scotton, E., Fracasso, D. S., Rosa, A. R., Branco, C. S., & Salvador, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2972968 · Cited by 77 · see citing works
Dhami, K., Churchward, M. A., Baker, G. B., & Todd, K. G. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.07.006 · Cited by 76 · see citing works
Zhu, C., Xiong, Z., Chen, X., Peng, F., Hu, X., Chen, Y., & Wang, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035125 · Cited by 74 · see citing works
Davenport, C. M., Sevastou, I. G., Hooper, C., & Pocock, J. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06485.x · Cited by 67 · see citing works
Increasing CNS Noradrenaline Reduces EAE Severity
Simonini, M. V., Polak, P. E., Sharp, A. J., McGuire, S. O., Galea, E., & Feinstein, D. L. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9182-2 · Cited by 69 · see citing works
Hsiao, C., Wang, D., Kaushal, A., & Saligan, L. N. (2012) · Cancer Nursing · doi:10.1097/ncc.0b013e318263f514 · Cited by 69 · see citing works
Lee, M., McGeer, E. G., Kodela, R., Kashfi, K., & McGeer, P. L. (2013) · Glia · doi:10.1002/glia.22553 · Cited by 69 · see citing works
Self-citationObuchowicz, E., Bielecka, A., Paul-Samojedny, M., Pudełko, A., & Kowalski, J. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.08.002 · Cited by 68 · see citing works
Mizoguchi, Y., Monji, A., Kato, T. A., Seki, Y., Gotoh, L., Horikawa, H., Suzuki, S. O., Iwaki, T., Yonaha, M., Hashioka, S., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901326 · Cited by 67 · see citing works
Self-citationSnijders, G. J. L., Sneeboer, M. A. M., Fernández-Andreu, A., Udine, E., (NBB-Psy), P. D. P. O. T. N. B. B., Boks, M. P., Ormel, P. R., van Berlekom, A. B., van Mierlo, H. C., Böttcher, C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00896-z · Cited by 65 · see citing works
Mind and body: how the health of the body impacts on neuropsychiatry
Renoir, T., Hasebe, K., & Gray, L. J. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00158 · Cited by 62 · see citing works
Rimmerman, N., Verdiger, H., Goldenberg, H., Naggan, L., Robinson, E., Kozela, E., Gelb, S., Reshef, R., Ryan, K. M., Ayoun, L., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01338-0 · Cited by 62 · see citing works
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
Creeden, J. F., Imami, A. S., Eby, H. M., Gillman, C., Becker, K. N., Reigle, J., Andari, E., Pan, Z. K., O’Donovan, S. M., McCullumsmith, R. E., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111437 · Cited by 61 · see citing works
A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue
Elsayed, M., & Magistretti, P. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00468 · Cited by 59 · see citing works
Gut Bacteria and Neuropsychiatric Disorders
Dicks, L. M. T., Hurn, D., & Hermanus, D. (2021) · Microorganisms · doi:10.3390/microorganisms9122583 · Cited by 61 · see citing works
Valvassori, S. S., Tonin, P. T., Varela, R. B., Carvalho, A. F., Mariot, E., Amboni, R. T., Bianchini, G., Andersen, M. L., & Quevedo, J. (2015) · Bipolar Disorders · doi:10.1111/bdi.12299 · Cited by 57 · see citing works
Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications
Braun, D. J., Madrigal, J. L. M., & Feinstein, D. L. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140828220938 · Cited by 56 · see citing works
Umathe, S. N., Bhutada, P., Jain, N. S., Mundhada, Y. R., Borkar, S. S., & Dhumal, B. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.07.001 · Cited by 54 · see citing works
Neuroimmune endocrine effects of antidepressants
de Carvalho, L. A. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16409 · Cited by 52 · see citing works
Ghasemi, M., Sadeghipour, H., Poorheidari, G., & Dehpour, A. R. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.032 · Cited by 51 · see citing works
Perić, I., Stanisavljević, A., Gass, P., & Filipović, D. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0807-9 · Cited by 51 · see citing works
Litteljohn, D., Mangano, E. N., & Hayley, S. P. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06371.x · Cited by 51 · see citing works
Nitric oxide: Antidepressant mechanisms and inflammation
Ghasemi, M. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.04.004 · Cited by 49 · see citing works
Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
Lee, M., McGeer, E. G., & McGeer, P. L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0488-8 · Cited by 50 · see citing works
Self-citationIida, T., Yoshikawa, T., Matsuzawa, T., Naganuma, F., Nakamura, T., Miura, Y., Mohsen, A. S., Harada, R., Iwata, R., & Yanai, K. (2015) · Glia · doi:10.1002/glia.22812 · Cited by 48 · see citing works
Sex Differences in the Inflammatory Consequences of Stress: Implications for Pharmacotherapy
Martínez-Muñiz, G. A., & Wood, S. K. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266205 · Cited by 47 · see citing works
Tian, L., Hui, C. W., Bisht, K., Tan, Y., Sharma, K. P., Chen, S., Zhang, X., & Tremblay, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.007 · Cited by 47 · see citing works
Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation
Nava, R. G., Adri, A. S., Filgueiras, I. S., Nóbile, A. L., Barcelos, P. M., Corrêa, Y. L. G., de Oliveira, S. F., Cabral‐Miranda, G., Dias, H. D., Schimke, L. F., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03532-y · Cited by 51 · see citing works
Abdel‐Salam, O. M. E., Morsy, S., & Sleem, A. A. (2012) · Europe PMC (PubMed Central) · doi:10.17877/de290r-5131 · Cited by 46 · see citing works
Litteljohn, D., Cummings, A., Brennan, A., Gill, A., Chunduri, S., Anisman, H., & Hayley, S. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.12.001 · Cited by 46 · see citing works
Fornaro, M., Martino, M., Battaglia, F., Colicchio, & Perugi, G. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16382 · Cited by 45 · see citing works
Tankersley, A. N., Frank, M. B., Bebak, M., & Brennan, R. E. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-17 · Cited by 44 · see citing works
Jinno, S., & Kosaka, T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.028 · Cited by 42 · see citing works
Kim, E.-A. L., Han, A. R., Choi, J.-Y., Ahn, J., Choi, S. Y., & Cho, S. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.06.022 · Cited by 42 · see citing works
Xu, Y., Liang, J., Sun, Y., Zhang, Y., Shan, F., Ge, J., & Xia, Q. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110108 · Cited by 41 · see citing works
Hamed, M. G. M., & Hagag, R. S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110140 · Cited by 42 · see citing works
Yang, J., Rui, B.-B., Chen, C., Chen, H., Xu, T., Xu, W. P., & Wei, W. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.016 · Cited by 40 · see citing works
Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia
Kato, T. A., Hayakawa, K., Monji, A., & Kanba, S. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00053 · Cited by 40 · see citing works
Self-citationEffect of tramadol on immune responses and nociceptive thresholds in a rat model of incisional pain
Liu, Y., Zhu, S., Wang, K., Feng, Z.-Y., & Chen, Q.-L. (2008) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b0820039 · Cited by 39 · see citing works
Preventing neurodegeneration by adrenergic astroglial excitation
Zorec, R., Parpura, V., & Verkhratsky, A. (2018) · FEBS Journal · doi:10.1111/febs.14456 · Cited by 39 · see citing works
Della, F. P., Abelaira, H. M., Réus, G. Z., Antunes, A. R., dos Santos, M. A. B., Zappellini, G., Steckert, A. V., Vuolo, F. S., Galant, L. S., Dal‐Pizzol, F., et al. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.09.018 · Cited by 38 · see citing works
Fluoxetine induces vasodilatation of cerebral arterioles by co‐modulating NO /muscarinic signalling
Ofek, K., Schoknecht, K., Melamed‐Book, N., Heinemann, U., Friedman, A., & Soreq, H. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01596.x · Cited by 37 · see citing works
DHA effects in Parkinson disease depression
Pomponi, M., Loria, G., Salvati, S., Biase, A. D., Conte, G. L., Villella, C., Righino, E., Ciciarelli, C., Bria, P., Torre, G. L., et al. (2014) · Basal Ganglia · doi:10.1016/j.baga.2014.03.004 · Cited by 37 · see citing works
Pathologic role of nitrergic neurotransmission in mood disorders
Ghasemi, M., Claunch, J. D., & Niu, K. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.002 · Cited by 37 · see citing works
- Authors
- Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., & Kanba, S.
- Affiliations
- Kyushu University (JP)
- University of British Columbia (CA)
- Research Institute of Environmental Medicine, Nagoya University (JP)
- Corresponding author
- Hashioka, Sadayuki
- Monji, Akira
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 206
- Issue
- 1
- Pages
- 33-42
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1970022478
- Cited by
- 198
- References
- 42
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 4 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 10 · 2018: 5 · 2017: 7 · 2016: 18 · 2015: 16 · 2014: 18 · 2013: 14 · 2012: 18
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- antidepressants, microglia, interferon-gamma, interleukin-6, nitric oxide, fluvoxamine, reboxetine, imipramine, lithium chloride, cAMP signaling, protein kinase A, microglial activation, depression, inflammatory cytokines, mood stabilizers
- MeSH terms
- Cyclic AMP, Animals, Antidepressive Agents, Antiviral Agents, Brain, Cell Line, Depressive Disorder, Dose-Response Relationship, Drug, Enzyme Inhibitors, Interferon-gamma, Mice, Inbred C57BL, Nitric Oxide, Neurotransmitter Uptake Inhibitors, Interleukin-6, Up-Regulation, Microglia, Cyclic AMP-Dependent Protein Kinases, Lithium Chloride, Antimanic Agents, MAP Kinase Signaling System, Mice, Cyclic AMP-Dependent Protein Kinase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review